Comparison of Choosing Free ALT or Free PMT for Reconstruction With Head and Neck Cancer
Overview
This study was designed to compare the outcome of the anteromedial thigh (AMT) and anterolateral thigh (ALT) flaps in head and neck cancer reconstruction.
Full Title of Study: “Comparison of the Outcome of Choosing Free Anterolateral Thigh or Free Posterolateral Thigh Flap for Reconstruction in Patients With Head and Neck Cancer”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: May 2, 2019
Detailed Description
To compare the results of the AMT and ALT flaps, this study aimed to compare their outcomes in head and neck cancer reconstruction under the condition of attenuating baseline patient and operative characteristics with the selection of propensity score-matched patient cohorts.
Interventions
- Other: ALT flap reconstruction
- Patients who underwent ALT free flap reconstruction after head and neck cancer surgery.
- Other: AMT flap reconstruction
- Patients who underwent AMT free flap reconstruction after head and neck cancer surgery.
Arms, Groups and Cohorts
- ALT&AMT free flap reconstruction
- Patients who underwent ALT or AMT free flap reconstruction after head and neck cancer surgery between March 1, 2008 and February 28, 2017
Clinical Trial Outcome Measures
Primary Measures
- survival or failure
- Time Frame: up to 6 months
- The primary free flap outcome was determined as its survival or failure.
Secondary Measures
- Complications
- Time Frame: up to 6 months
- The second outcome was the associated complications (fistula, hematoma, partial necrosis, and wound infection).
Participating in This Clinical Trial
Inclusion Criteria
- Patients who underwent ALT or AMT free flap reconstruction after head and neck cancer surgery between March 1, 2008 and February 28, 2017. Exclusion Criteria:
- Patients whose data were missing will be excluded.
Gender Eligibility: All
Minimum Age: 20 Years
Maximum Age: 100 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Chang Gung Memorial Hospital
- Provider of Information About this Clinical Study
- Sponsor
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.